Business Description
BB Biotech AG
NAICS : 325414
ISIN : CH0038389992
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.88 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | N/A | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 6/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year FCF Growth Rate | -5.6 | |||||
3-Year Book Growth Rate | -15.5 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.56 | |||||
9-Day RSI | 52.94 | |||||
14-Day RSI | 51.85 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History |
---|
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Payout Ratio | 0.46 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 0.56 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Net Margin % | 92.4 | |||||
FCF Margin % | 40.48 | |||||
ROE % | 10.04 | |||||
ROA % | 8.82 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 9.4 | |||||
Forward PE Ratio | 21.39 | |||||
PE Ratio without NRI | 9.4 | |||||
Shiller PE Ratio | 4.95 | |||||
PS Ratio | 8.68 | |||||
PB Ratio | 0.92 | |||||
Price-to-Tangible-Book | 0.92 | |||||
Price-to-Free-Cash-Flow | 20.92 | |||||
Price-to-Operating-Cash-Flow | 20.92 | |||||
EV-to-Revenue | 9.24 | |||||
EV-to-FCF | 22.4 | |||||
Price-to-Projected-FCF | 0.73 | |||||
Price-to-Graham-Number | 0.62 | |||||
FCF Yield % | 5.17 | |||||
Forward Rate of Return (Yacktman) % | 13.37 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with GREY:BBAGF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Ā
Total Annual Return % Ā
BB Biotech AG Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 289.69 | ||
EPS (TTM) ($) | 4.867 | ||
Beta | 0 | ||
Volatility % | 2.93 | ||
14-Day RSI | 51.85 | ||
14-Day ATR ($) | 0.005526 | ||
20-Day SMA ($) | 76.05789 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 76.05789 - 76.05789 | ||
Shares Outstanding (Mil) | 54.85 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
BB Biotech AG Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
BB Biotech AG Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
BB Biotech AG Frequently Asked Questions
What is BB Biotech AG(BBAGF)'s stock price today?
When is next earnings date of BB Biotech AG(BBAGF)?
Does BB Biotech AG(BBAGF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |